Total submissions: 6
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Neuberg Centre For Genomic Medicine, |
RCV000768570 | SCV006077033 | pathogenic | Leukodystrophy, hypomyelinating, 18 | 2024-02-01 | criteria provided, single submitter | clinical testing | The missense c.565A>G (p.Asn189Asp) variant in DEGS1 gene has been reported previously in individual(s) affected with DEGS1- related leukodystrophy (Pant et al., 2019). Additional functional studies will be required to prove the pathogenicity of this variant. |
| Ce |
RCV002061034 | SCV002496991 | pathogenic | not provided | 2022-01-01 | criteria provided, single submitter | clinical testing | |
| Institute of Human Genetics, |
RCV000768570 | SCV001442997 | pathogenic | Leukodystrophy, hypomyelinating, 18 | 2020-06-01 | criteria provided, single submitter | clinical testing | PS3, PM2, PM3, PP1_Moderate |
| SIB Swiss Institute of Bioinformatics | RCV000768570 | SCV001146814 | pathogenic | Leukodystrophy, hypomyelinating, 18 | 2019-09-25 | criteria provided, single submitter | curation | This variant is interpreted as a Pathogenic for Leukodystrophy, hypomyelinating, 18, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PM3, PS3, PP1-Moderate. |
| The Morris Kahn Laboratory of Human Genetics, |
RCV000786045 | SCV000897760 | pathogenic | Leukodystrophy | 2019-04-10 | criteria provided, single submitter | clinical testing | DEGS1 inactivating mutations were found to segregate with a form of leukodystrophy in a consanguineous family with 4 affected individuals. Pathogenicity was evaluated by several means. |
| OMIM | RCV000768570 | SCV000899274 | pathogenic | Leukodystrophy, hypomyelinating, 18 | 2020-04-02 | no assertion criteria provided | literature only |